Barely Significant
← all excerpts

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency.

Onco Targets Ther · 2016 · PMC4892850 · PMID 27313461

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

highly significantP <0.05actually significant
The A-PTX-SF-NPs group showed slower tumor growth and smaller relative tumor volumes than the PTX-SF-NPs group and the differences were highly significant ( P <0.05) except on Day 4 ( P =0.068).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.